These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 10831388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN, Castelo-Branco MT, Lannes-Vieira J, Gattass CR.
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ, Wrightsman RA, Stryker GA, Manning JE.
    J Immunol; 1997 Jun 01; 158(11):5330-7. PubMed ID: 9164953
    [Abstract] [Full Text] [Related]

  • 10. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
    Martin D, Tarleton R.
    Immunol Rev; 2004 Oct 01; 201():304-17. PubMed ID: 15361249
    [Abstract] [Full Text] [Related]

  • 11. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF, Lynch RG, Kirchhoff LV.
    J Immunol; 1993 Dec 15; 151(12):7038-47. PubMed ID: 8258708
    [Abstract] [Full Text] [Related]

  • 12. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
    Lüthje K, Cramer SO, Ehrlich S, Veit A, Steeg C, Fleischer B, Bonin Av, Breloer M.
    Eur J Immunol; 2006 Aug 15; 36(8):2035-45. PubMed ID: 16841299
    [Abstract] [Full Text] [Related]

  • 13. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.
    Cardillo F, Postol E, Nihei J, Aroeira LS, Nomizo A, Mengel J.
    Immunology; 2007 Dec 15; 122(4):584-95. PubMed ID: 17635611
    [Abstract] [Full Text] [Related]

  • 14. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ, Dohlsten M, Rosendahl A, Ohlsson L, Søgaard M, Andersson J, Andersson U.
    Br J Cancer; 1999 Sep 15; 81(2):359-66. PubMed ID: 10496366
    [Abstract] [Full Text] [Related]

  • 15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 15; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.
    Skaro AI, Liwski RS, Zhou J, Vessie EL, Lee TD, Hirsch GM.
    Cardiovasc Res; 2005 Jan 01; 65(1):283-91. PubMed ID: 15621057
    [Abstract] [Full Text] [Related]

  • 18. T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection.
    Cobb D, Hambright D, Smeltz RB.
    J Leukoc Biol; 2010 Nov 01; 88(5):965-71. PubMed ID: 20807701
    [Abstract] [Full Text] [Related]

  • 19. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
    Wrightsman RA, Luhrs KA, Fouts D, Manning JE.
    Parasite Immunol; 2002 Aug 01; 24(8):401-12. PubMed ID: 12406194
    [Abstract] [Full Text] [Related]

  • 20. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG.
    J Immunol; 1988 Jun 15; 140(12):4342-7. PubMed ID: 3131431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.